Investment opportunities

Glaucoma remains the leading cause of irreversible blindness worldwide. There is a well-defined need for a long lasting and highly effective treatment to prevent global blindness. This makes the OptiShunt a very attractive investment opportunity for scientific research foundations.

 

The rapidly growing, billion dollar per annum glaucoma device market also means that the OptiShunt offers private equity investors and commercial partners the potential for excellent return on investment.

Contact Liqid Medical for upcoming investment opportunities >>

Contact

Contact Dr. McClunan to find out more about the OptiShunt project and its implications in ophthalmology.

 

Call: +27 (0)84 604 7600
Email: daemon@liqidmedical.com
Or write using the contact form:
 

Located in Cape Town, South Africa - World Design Capital 2014

© 2017 Copyright reserved. Website created by CassandraGroenewald.com